Sensome

Lung cancer is the leading cause of cancer-related deaths worldwide, responsible for over 2 million deaths every year. The diagnosis involves obtaining a tissue sample from a suspected lesion through biopsy, commonly performed during bronchoscopy. Early detection of lung cancer significantly improves patient survival and a failed biopsy can delay diagnosis. A real-time tool-in-lesion confirmation system can guide the bronchoscopy procedure to relevant biopsy sites, improving sampling yield, and accelerating diagnosis and treatment. We have demonstrated in a clinical feasibility study that Sensome’s tissue-sensing technology can successfully be used to differentiate healthy lung from cancerous tissue in a biopsy procedure.

From the manufacturer's own website. Source